The report on Prostate Cancer Therapeutics Market by Component (Hormonal therapy( LHRH antagonists,
LHRH agonists and Anti-androgen), Chemotherapy, Immunotherapy, Radiation therapy) trends analysis and
forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as
North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Prostate Cancer
Therapeutics Market is projected to grow at a CAGR of around 9.9% in terms of value over the period of 2017-
2023. The growth in the world market is primarily driven by significant contribution by North America (Leading
region) region to this market.
Get a Sample Request
https://www.infiniumglobalresearch.com/reports/sample_request/334
Innovations in the development of new drugs and therapies, large number of new drugs entering into the
market with FDA approval, high growth in hormone-refractory prostate cancer therapeutics market, and rise
in base of aging population are the key driving factors for the growth of this market. In addition, rise in
prevalence of prostate cancer, changing lifestyle habits of populations, increased patient’s healthcare
awareness, and increasing demand for non-invasive therapies are further expected to propel the market
growth in the coming years. Along with these driving factors, the market for prostate cancer is facing some
challenges such as time consuming regulatory compliance and high cost of prostate drugs. However, the
market for prostate cancer is likely to rise in the future due to the large number of ongoing innovations for the
treatment of prostate cancer.
Geographically, North America is the leading contributor to the market and is expected to retain its position
during the forecast period due to high awareness, large base of prostate cancer patients, rise in investments,
and various initiatives by government in the healthcare sector. However, Asia-Pacific market is expected to
grow at a faster rate during the forecast period. This is predominantly due to increased healthcare awareness,
Infinium Global Research